Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Colorcon
Harvard Business School
Mallinckrodt
Johnson and Johnson

Last Updated: December 6, 2022

CLINICAL TRIALS PROFILE FOR PALONOSETRON HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Palonosetron Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00306735 ↗ Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation. Completed Helsinn Healthcare SA Phase 2 2006-03-01 The primary purpose of this study is to explore the efficacy of three different dose schedules of palonosetron for the prevention of emesis over a 7-day study interval in multiple myeloma patients.
NCT00306735 ↗ Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation. Completed Eisai Inc. Phase 2 2006-03-01 The primary purpose of this study is to explore the efficacy of three different dose schedules of palonosetron for the prevention of emesis over a 7-day study interval in multiple myeloma patients.
NCT00343460 ↗ APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer Completed Heron Therapeutics Phase 3 2006-06-01 This randomized phase III trial is studying APF530 and dexamethasone to see how well they work compared with palonosetron and dexamethasone in preventing nausea and vomiting in patients receiving chemotherapy for cancer.
NCT00343863 ↗ Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer Completed National Cancer Institute (NCI) N/A 2006-01-01 RATIONALE: Antiemetic drugs, such as dexamethasone, ondansetron hydrochloride, and palonosetron hydrochloride, may help lessen or prevent nausea and vomiting caused by chemotherapy. PURPOSE: This clinical trial studies how well giving dexamethasone together with ondansetron hydrochloride or palonosetron hydrochloride works in preventing nausea and vomiting in patients receiving doxorubicin hydrochloride and cyclophosphamide for early stage breast cancer
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Palonosetron Hydrochloride

Condition Name

Condition Name for Palonosetron Hydrochloride
Intervention Trials
Chemotherapy-Induced Nausea and Vomiting 30
Postoperative Nausea and Vomiting 16
Nausea 14
Vomiting 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Palonosetron Hydrochloride
Intervention Trials
Vomiting 91
Nausea 76
Postoperative Nausea and Vomiting 23
Breast Neoplasms 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Palonosetron Hydrochloride

Trials by Country

Trials by Country for Palonosetron Hydrochloride
Location Trials
United States 280
China 25
Italy 22
Korea, Republic of 17
Brazil 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Palonosetron Hydrochloride
Location Trials
Ohio 15
Texas 15
Florida 13
South Carolina 13
New York 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Palonosetron Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Palonosetron Hydrochloride
Clinical Trial Phase Trials
Phase 4 20
Phase 3 34
Phase 2/Phase 3 3
[disabled in preview] 38
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Palonosetron Hydrochloride
Clinical Trial Phase Trials
Completed 72
Unknown status 15
Recruiting 12
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Palonosetron Hydrochloride

Sponsor Name

Sponsor Name for Palonosetron Hydrochloride
Sponsor Trials
Helsinn Healthcare SA 15
National Cancer Institute (NCI) 11
Eisai Inc. 11
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Palonosetron Hydrochloride
Sponsor Trials
Other 140
Industry 59
NIH 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Baxter
McKesson
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.